1 LATANOPROST | 30 of 1320 | 5720 prescriptions Less than 1% of all prescriptions | 5340 | 1000 patients 46% of all patients | < 11 | |
2 LEVOBUNOLOL HCL | 10 of 70 | 910 prescriptions Less than 1% of all prescriptions | | 260 patients 12% of all patients | < 11 | |
3 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 10 of 370 | 860 prescriptions Less than 1% of all prescriptions | 860 | 260 patients 12% of all patients | 260 patients 12% of all patients | |
4 LUMIGAN (BIMATOPROST) | 40 of 480 | 1430 prescriptions Less than 1% of all prescriptions | 1430 | 210 patients 10% of all patients | 210 patients 10% of all patients | |
5 BRIMONIDINE TARTRATE | 20 of 590 | 1090 prescriptions Less than 1% of all prescriptions | 1090 | 290 patients 13% of all patients | 290 patients 13% of all patients | |
6 DORZOLAMIDE HCL | 40 of 370 | 620 prescriptions Less than 1% of all prescriptions | | 180 patients 8% of all patients | < 11 | |
7 TIMOLOL MALEATE | 410 of 790 | 230 prescriptions Less than 1% of all prescriptions | 230 | 120 patients 5% of all patients | 120 patients 5% of all patients | |
8 RESTASIS (CYCLOSPORINE) | 150 of 620 | 340 prescriptions Less than 1% of all prescriptions | 340 | < 11 | < 11 | |
9 TRAVATAN Z (TRAVOPROST) | 100 of 550 | 390 prescriptions Less than 1% of all prescriptions | 390 | < 11 | < 11 | |
10 XIIDRA (LIFITEGRAST) | 80 of 140 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
11 OLOPATADINE HCL | 180 of 320 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
12 PREDNISOLONE ACETATE | 310 of 590 | 150 prescriptions Less than 1% of all prescriptions | 150 | 110 patients 5% of all patients | 110 patients 5% of all patients | |
13 TOBRAMYCIN-DEXAMETHASONE (TOBRAMYCIN/DEXAMETHASONE) | 60 of 160 | 150 prescriptions Less than 1% of all prescriptions | | 110 patients 5% of all patients | < 11 | |
14 ERYTHROMYCIN (ERYTHROMYCIN BASE) | 150 of 360 | 240 prescriptions Less than 1% of all prescriptions | | 190 patients 9% of all patients | < 11 | A |